A leading Brazilian pharmaceutical company with more than 50 years in the market, Aché holds out-licensing partnerships in over 20 countries and a portfolio of more than 300 brands across Rx, OTC, dermocosmetics and nutraceutical markets. The company continuously invests in innovative product development, with promising NCEs in clinical development and a range of differentiated "me-better" products built on proprietary technology platforms.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen